Article Text

Download PDFPDF

Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay
Free
  1. H Yokota1,
  2. F Mori1,
  3. K Kai1,
  4. T Nagaoka1,
  5. N Izumi1,
  6. A Takahashi1,
  7. T Hikichi1,
  8. A Yoshida1,
  9. F Suzuki2,
  10. Y Ishida3
  1. 1Department of Ophthalmology, Asahikawa Medical College, Asahikawa, Japan
  2. 2Faculty of Applied Biological Science, Gifu University, Gifu, Japan
  3. 3Preveqol Co, Tokyo, Japan
  1. Correspondence to: Harumasa Yokota MD, Department of Ophthalmology, Asahikawa Medical College, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510 Japan; atokoy18asahikawa-med.ac.jp

Abstract

Aim: To investigate the serum levels of prorenin and its correlation with the severity of diabetic retinopathy (DR).

Methods: 248 patients with diabetes and 108 control subjects were divided into four groups: no-DR (n = 146), no proliferative diabetic retinopathy (no-PDR) (n = 78), PDR (n = 24), and controls (n = 108). Serum levels of prorenin from all subjects were measured using the new antibody activating direct kinetic (AAD-PR) assay. The serum prorenin levels were compared among the groups.

Results: The serum levels of prorenin in the control, no-DR, no-PDR, and PDR groups, respectively, were 109.1 (66.1), 194.6 (160.4), 271.5 (220.3), and 428.4 (358.4) pg/ml (mean (SD)). Prorenin in the PDR group was remarkably high compared with the control and no-DR groups (p<0.0001) and with the no-PDR group (p = 0.002). Serum levels of prorenin increased with increasingly severe retinopathy. No correlation was found between the prorenin level and the duration of disease or HbA1c.

Conclusions: The serum levels of prorenin in patients with PDR were found to be markedly high using the AAD-PR assay. Increased levels of prorenin in diabetes may have an important role in the pathogenesis of DR.

  • AAD-PR, antibody activating direct prorenin
  • DR, diabetic retinopathy
  • PDR, proliferative diabetic retinopathy
  • RAS, renin-angiotensin system
  • antibody activating direct prorenin assay
  • diabetes
  • diabetic retinopathy
  • prorenin
  • renin-angiotensin system
  • AAD-PR, antibody activating direct prorenin
  • DR, diabetic retinopathy
  • PDR, proliferative diabetic retinopathy
  • RAS, renin-angiotensin system
  • antibody activating direct prorenin assay
  • diabetes
  • diabetic retinopathy
  • prorenin
  • renin-angiotensin system

Statistics from Altmetric.com

Footnotes

  • The authors have no proprietary interest in any aspect of this report.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.